BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 638002)

  • 21. Safeguards in the use of topical mafenide (Sulfamylon) in burned patients.
    Shuck JM; Moncrief JA
    Am J Surg; 1969 Dec; 118(6):864-70. PubMed ID: 4902276
    [No Abstract]   [Full Text] [Related]  

  • 22. The use of mefenide in the local treatment of burns.
    Magliacani G; Savoia D; Martinetto P
    Panminerva Med; 1972; 14(7-8):249-56. PubMed ID: 4680911
    [No Abstract]   [Full Text] [Related]  

  • 23. The effects of topical mafenide acetate application on skin graft survival in bacterial contaminated wounds.
    Baver Acaban M; Sarı A; Demirbağ HO; Ersöz G; Aktaş S
    Burns; 2024 Mar; 50(2):433-443. PubMed ID: 37985270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A simple cost-saving measure: 2.5% mafenide acetate solution.
    Ibrahim A; Fagan S; Keaney T; Sarhane KA; Hursey DA; Chang P; Sheridan R; Ryan C; Tompkins R; Goverman J
    J Burn Care Res; 2014; 35(4):349-53. PubMed ID: 24043238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mafenide acetate in burn treatment.
    Haynes BW
    N Engl J Med; 1971 Jun; 284(23):1324. PubMed ID: 5576444
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison between topical honey and mafenide acetate in treatment of auricular burn.
    Hashemi B; Bayat A; Kazemei T; Azarpira N
    Am J Otolaryngol; 2011; 32(1):28-31. PubMed ID: 20015812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The antifibrinolytic activity of sulfamylon solution.
    Aldridge JH; Weisdorf DJ; Kucan JO
    Plast Reconstr Surg; 1988 Aug; 82(2):281-4. PubMed ID: 3041428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study of burns which have been treated with amniotic membrane and Mafylon cream].
    Rattano S
    Thai J Nurs; 1975 Jan; 24(1):17-31. PubMed ID: 1051718
    [No Abstract]   [Full Text] [Related]  

  • 29. Systemic absorption of amphotericin B with topical 5% mafenide acetate/amphotericin B solution for grafted burn wounds: is it clinically relevant?
    Pendleton RA; Holmes JH
    Burns; 2010 Feb; 36(1):38-41. PubMed ID: 19481350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydrofiber Dressing Saturated With Mafenide Acetate Extends the Duration of Antimicrobial Activity.
    Kahn SA; Afshari A; Nguyen L; Shinha T; Huff T; Montgomery AC; Stratton C; Summitt B
    J Burn Care Res; 2017; 38(4):e704-e707. PubMed ID: 27775984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experimental studies on the healing times of burns in relation to various methods of treatment (scab, napaltan, nutritive solution)].
    Moldt U; Klein P
    Langenbecks Arch Chir; 1974; Suppl():253-6. PubMed ID: 4464418
    [No Abstract]   [Full Text] [Related]  

  • 32. Mafenide acetate cream: a review.
    Drugs; 1971; 1(6):434-60. PubMed ID: 4948236
    [No Abstract]   [Full Text] [Related]  

  • 33. Topical application of mafenide acetate. Its association with erythema multiforme and cutaneous reactions.
    Affee HS; Dressler DP
    Arch Dermatol; 1969 Sep; 100(3):277-81. PubMed ID: 5822369
    [No Abstract]   [Full Text] [Related]  

  • 34. [Algimaf treatment of trophic ulcers].
    Sogomonian LM; Iakubovich VS
    Vestn Dermatol Venerol; 1989; (5):69-72. PubMed ID: 2773588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Burn wound sepsis: effect of delayed treatment with topical chemotherapy on survival.
    Salisbury RE; Bevin AG; Steinkraus GE; Enterline DS
    J Trauma; 1980 Feb; 20(2):120-2. PubMed ID: 7354493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Off-label drug use in WOC nursing: issues related to use of mafenide acetate to treat infected chronic wounds.
    Breton DW
    J Wound Ostomy Continence Nurs; 2001 Sep; 28(5):253-8. PubMed ID: 11557929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mafenide (Sulfamylon) inhibits plasmin fibrinolytic activity.
    Weisdorf DJ; Aldridge JH
    Thromb Haemost; 1988 Jun; 59(3):440-4. PubMed ID: 2973151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fatal hemolysis from mafenide treatment of burns in a patient with glucose-6-phosphate dehydrogenase deficiency. Case report.
    Marsicano AR; Hutton JJ; Bryant WM
    Plast Reconstr Surg; 1973 Aug; 52(2):197-9. PubMed ID: 4722683
    [No Abstract]   [Full Text] [Related]  

  • 39. Silver debate continue.
    Hermans MH
    J Wound Care; 2011 Jun; 20(6):286. PubMed ID: 21727878
    [No Abstract]   [Full Text] [Related]  

  • 40. The mafenide story.
    Bandmann HJ; Breit R
    Br J Dermatol; 1973 Aug; 89(2):219-21. PubMed ID: 4269480
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.